ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1492

Histone Deacetylase 1 But Not 2 Is Highly Expressed In The Lymphocyte Foci In The Labial Glands Of Patients With Sjogren’s Syndrome

Juan Guo and Wei Zhou, Department of Rheumatology and Immunology, Peking University First Hospital, Beijing, China

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Epigenetics, lymphocytes and pathogenesis, Sjogren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Sjögren's Syndrome: Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Sjogren’s syndrome (SS) is an autoimmune disease with abnormally infiltrating lymphocytes in exocrine glands expressing Th1 cytokines and increased incidence of lymphoma. Histone deacetylases (HDACs) regulate the state of acetylation of histones and many other intracellular proteins, and their role in the pathogenesis of malignancies has been established. HDAC1 and 2 may also affect the balance of Th1 and Th2 immune response. The aim of this study is to investigate whether HDAC1 and 2 are abnormally expressed in the salivary glands of SS. 

Methods:  Labial gland biopsies were performed in 55 patients, among them 25 were diagnosed as SS. The expression of HDAC1 and 2 were investigated by immunohistochemistry and immunofluorescence (IF). The HDACs expression level was semi-quatatvely analyzed by counting the number of positively stained cells in randomly chosen microscopic fields. The difference of HDAC expression level in different locus was analyzed by t test. 

Results: HDAC1 was highly expressed in the infiltrating lymphocytic foci in the labial glands of patients with SS. The proportion of HDAC1+ cells in lymphocytic foci was higher than that in interstitium (0.66±0.24 vs 0.26±0.08, p<0.01). Concerning the expression of HDAC1 in lymphocytes outside the foci, the number of HDAC1+ cells in the interstitium of labial glands was higher in SS patients than that in non-SS patients (21±11/hpf vs 11±6/hpf, p<0.05). IF showed that HDAC1 was mainly expressed in CD4+ T cells. HDAC2 was not detected in the labial glands comparing positive control staining of tonsil tissue. The expression level of HDAC1 was not associated with the IgG level and presence of autoantibodies in patients with SS.

Conclusion:  The expression of HDAC1 is elevated in the lymphocytic foci in SS and may be involved in its pathogenesis. Thus, inhibiting HDAC1 specifically is a potential therapeutic strategy of SS that is worthy of further investigation.


Disclosure:

J. Guo,
None;

W. Zhou,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/histone-deacetylase-1-but-not-2-is-highly-expressed-in-the-lymphocyte-foci-in-the-labial-glands-of-patients-with-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology